Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль
- Войти
- Зарегистрироваться

Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0

Галерея

Advisory Letters
Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-25 By FDA
Patient Engagement Collaborative
Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
FDA Investigating Deaths Due to Acute Liver Failure in Non-ambulatory Duchenne Muscular Dystrophy Patients Following ELEVIDYS
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-24 By FDA
Toki Slimming Candy may be harmful due to hidden drug ingredients
Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
Weight Loss Product Notifications
Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
FIBRYGA
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-24 By FDA
Ongoing | Cancer Accelerated Approvals
Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
Competitive Generic Therapy Approvals
Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
Pfizer-BioNTech COVID-19 Vaccine
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-24 By FDA
Moderna COVID-19 Vaccine
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-06-24 By FDA
Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-24
Human medicines European public assessment report (EPAR): Miglustat Gen.Orph, miglustat, Date of authorisation: 09/11/2017, Revision: 12, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-24
Laboratory Information Bulletins
Source: FDA - What's New: Drugs RSS Feed Published on 2025-06-24 By FDA
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-24
Human medicines European public assessment report (EPAR): Aripiprazole Sandoz, aripiprazole, Date of authorisation: 20/08/2015, Revision: 12, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-06-24

Предыдущие записи

Тема: Scaffold от Danny Cooper.